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Introduction 
Advanced genetic testing has enabled detection of copy number variations 
(CNVs) which were previously undetectable.  The 15q11.2 microdeletion is an example 
of this sort of CNV. Chromosome 15q11 to q13 is known to be a highly unstable region 
and therefore associated with high frequency of mutation (Murthy et al, 2007). 
Specifically, the presence of repeat sequences in low copy numbers at some regions 
within 15q11 to q13 has created common break point regions including BP1, BP2, and 
BP3 (Murthy et al, 2007). 15q11.2 microdeletions encompass a lost copy from BP1 to 
BP2. The four genes in this region are NIPA1, NIPA2, CYFIP1, and TUBGCP5 (De wolf 
et al, 2013), and the deletion spans from 20,306,549bp to 20,777,695bp on 
chromosome 15, or approximately about 470 kb (Stefansson et al, 2008). Although 
15q11.2 is next to the region associated with Prader-Willi syndrome and Angelman 
syndrome, it is not overlapping. These two conditions are related specifically to the 
region between BP2 and BP3. None of the four genes in 15q11.2 region are known to 
be imprinted, in contrast to some genes in adjacent bands.  
Deletions in 15q11.2 are known to increase the risk of neurodevelopmental 
disorders. Specifically, 15q11.2 deletions have been associated with conditions such as 
developmental delay, autism spectrum disorder, schizophrenia, epilepsy, dyslexia, and 
dyscalculia (Burnside et al, 2011; Cooper et al, 2011; De Kovel et al, 2010; De wolf et 
al, 2013; Doornbos et al, 2009; Murthy et al, 2007; Stefansson et al, 2008; Stefansson 
et al, 2014; Von der Lippe et al, 2010). However, like many other recently detected 
CNVs, 15q11.2 deletions lack phenotypic specificity. This deletion can manifest with 
different symptoms in different individuals. To further complicate the matter, 15q11.2 
deletions, like many other newly detectable CNVs, are present in the population among 
those who do not present with any clinically significant symptoms (Stefansson et al, 
2014). Therefore, having this deletion creates a susceptibility to some 
neurodevelopmental disorders, but it is not necessarily causal. Lack of any direct 
associated phenotype in some carriers of this deletion makes it difficult to predict 
outcomes.  Therefore, it can leave clinicians, such as genetic counselors, challenged to 
interpret and communicate the meaning of these results to the patients and families 
(Burnside et al, 2011; Chaste et al, 2014; De wolf et al, 2013).  
There has been some speculation regarding the possible presence of 
intermediate phenotypes in 15q11.2 deletion carriers who are not affected (De Wolf et 
al, 2013, Stefansson et al, 2014).  This hypothesis was examined in a paper published 
in 2014 by Stefansson et al. Stefansson looked for relationships between individuals 
harboring CNVs known to increase risk for neurodevelopmental disease and altered 
cognition. The selection of CNVs was based on a literature review to identify those 
known to be associated with schizophrenia or autism, including 15q11.2 deletions. 
Subjects were recruited from four groups: carriers of a CNV associated with a 
neuropsychiatric disorder, including 15q11.2 deletion carriers, carriers of other CNVs 
not associated with neuropsychiatric disorders, controls with no CNVs, and patients with 
schizophrenia. Subjects were all between 18 to 65 years old (Stefansson e al, 2014). 
Participants were tested for cognitive functions including attention, spatial 
working memory, logical memory, executive functioning, cognitive flexibility, language 
and speed processing, using standardized tests such as Mini International 
Neuropsychiatric Interview (M.I.N.I.)(Stefansson et al, 2014). According to Stefansson 
these cognitive functions are known to be affected in individuals with schizophrenia. In 
addition, subjects were tested for dyslexia and dyscalculia (Stefansson et al, 2014). 
In this study, Stefansson found that 15q11.2 deletion carriers’ performance on 
tests of cognitive function fell between those of general population and patients with 
schizophrenia. The discrepancy with the general population was greatest for dyslexia 
and dyscalculia (Stefansson et al, 2014).  Stefansson deduced that the cognitive activity 
of carriers fell somewhere between the non-carriers and patients with schizophrenia, 
providing support for this hypothesis (Stefansson et al, 2014). 
In order to further study the effect of CNVs on a carrier’s brain, Stefansson, 
utilized magnetic resonance imaging (MRI). Carriers of a 15q11.2 deletion were found 
to have reduced grey matter volume in anterior cingulate cortex and left insula, reduced 
white matter volume in temporal lobe, and increased corpus callosum volume. 
Interestingly, the reduced grey matter observed in these carriers is similar to that found 
in individuals with dyslexia and dyscalculia. Stefansson concluded that perhaps 15q11.2 
events are associated with specific aspects of cognition and brain structure (Stefansson 
et al, 2014). 
 Prior to Stefansson’s work, Murthy et al, in 2007, published the first case report 
on a three and a half year old boy with a 253 Kb deletion in 15q11.2, between bp1 and 
bp2. Prior to this report, other reported cases of 15q11.2 deletions were larger and not 
limited to the region between bp1 and bp2 (Butler 2004, and Milner 2005). Those cases 
had deletions that included the region between BP2 and BP3, and hence usually a 
diagnosis of Prader-Willi syndrome or Angelman syndrome.  
Murthy reported on a patient with mental retardation, developmental delay and 
speech problems. The deletion was found to be paternally inherited. The child’s father 
had similar but milder symptoms (Murthy et al, 2007). However, Murthy did not 
speculate any reason for the milder presentation in the father.  
Doornbos et al, published the second case report, reporting on 9 cases in 2009.  
Probands all harbored 15q11.2 deletions and manifested developmental delay, mental 
retardation, dysmorphic facial features and behavioral problems. Behavioral problems 
encompassed autism, attention deficit hyperactivity disorder (ADHD), and obsessive-
compulsive disorder (OCD). A control population of 350 was screened, and no deletion 
carriers were found. This group concluded that there might be a correlation between 
15q11.2 deletions and developmental delay and mental retardation. In this study, 7 of 
the 9 reported patients were noted to have inherited the deletion from an unaffected or a 
mildly affected parent (Doornbos et al, 2009). Again, no rationale for the milder 
presentation of these individuals was offered. 
In 2010, Von der Lippe et al, reported on 7 patients with the same symptoms as 
those described by Doornbos patients, except facial dysmorphism. This study provided 
additional support for the association of developmental delay, mental retardation and 
behavioral problems with 15q11.2 deletions (Von der Lippe et al, 2010). 
The first large study of 15q11.2 deletions was done in 2008, a year after the first 
case report. Investigators were interested to know whether there was an association 
between schizophrenia and three recently discovered common deletions, including 
15q11.2. They screened a population of 4,718 patients with schizophrenia for the three 
deletions, and compared it to the prevalence of the deletion in a control population of 
41,194. With regards to 15q11.2 deletions, 26 of 4,718 (0.55%) patients with 
schizophrenia and psychosis were carriers while only 79 of 41,194 (0.19%) controls had 
the deletion (Stefansson et al, 2008). This group concluded that indeed there was an 
association between schizophrenia and 15q11.2 deletions.  
In 2012, Van Den Bossche et al, confirmed this association by screening a 
different population of patients with schizophrenia as well as patients with bipolar 
disorder, major depressive disorder, and intellectual disability, for deletions in 15q11.2. 
15q11.2 deletions were found to be associated with increased susceptibility to both 
schizophrenia and intellectual disability. This group speculated that CNVs in this region 
could cause disturbances in brain development, which consequently can increase 
predisposition to different neuropsychiatric conditions (Van Den Bossche et al, 2012). 
In 2010, De Kovel et al looked at the association of five commonly reported 
deletions, including 15q11.2 deletions, with epilepsy. This study looked at the 
prevalence of these deletions in a patient population with common idiopathic 
generalized epilepsy syndrome, and 12 of 1234 (1%) patients and 6 of 3022 (0.2%) 
controls were found to have 15q112 microdeletions (Kovel et al, 2010). Therefore, this 
group concluded a susceptibility to epilepsy did exist for carriers of this deletion. All 
these cases were inherited from a non-affected parent, and again no explanation for this 
finding was offered. 
In 2011, Cooper et al, screened a large sample of 15,767 children with 
intellectual disability and developmental delay for the presence of 15q11.2 deletion, and 
compared it to 8329 unaffected adults patients. This group found the 15q11.2 deletion in 
one out of every 167 affected patients with intellectual disability and developmental 
delay, providing support for the association of 15q11.2 deletion with intellectual disability 
and developmental delay (Cooper et al, 2011). 
Additionally, Burnside et al, in the same year, screened a total of 3,992 patients. 
Patients were affected with autism, developmental delay, motor and language delays, 
and behavioral problems. A total of 0.86% of the 3,992 were found to carry either 
duplication or a deletion (0.41% deletion) in the 15q11.2 region. However, only 0.38% of 
6,329 controls were found to carry a mutation in 15q11.2 (Burnside et al, 2011). Most of 
the mutations in Burnside study were inherited from unaffected parents. Possible 
explanations for these results included “reduced penetrance, altered gene dosage on a 
particular genetic background, or a susceptibility region as reported for other areas of 
the genome implicated in autism and behavior disturbances” (Burnside, 2011).  
The current study assessed the cognitive phenotypes of 15q11.2 deletion 
carriers. As demonstrated above, unaffected parents harboring a 15q11.2 deletion were 
observed in most of the studies. Finding a possible intermediate or associated 
phenotype in the 15q11.2 deletion carriers would not only provide important insight into 
this deletion’s neurobiology, but also aid clinicians to interpret the outcome of such 
deletions for patients with increased certainty.  
Materials and Methods 
	  	   A cohort of 27 individuals with 15q11.2 deletion was recruited, using online social 
media tools, including Facebook. Sex, age and education level of participants are 
summarized in Table 1. 74.1% of this cohort consists of individuals without a clinical 
diagnosis, who harbor a 15q11.2 deletion, and are family members (parents and 
siblings) of individuals with a diagnosis.  
 All participants have deletions that include the 4 genes. The break point of all 
deletion carriers are (Hg18) = chr15: 20,316,792-20,851,728 (plus or minus 100kb 
either side) or (Hg19) = chr15: 22,748,621-23,328,986 (plus or minus 100kb either 
side). Blood or spit samples were collected from the subjects. DNA prepared from these 
samples was tested in the Abrahams lab for the presence of 15q11.2 deletion using 
TaqMan technology. 
To investigate cognitive function in 15q11.2 deletion carriers we used an online 
platform, called Lumosity, which employs well established neuropsychology tests to look	  
at cognitive functions including memory, speed, attention, flexibility, and problem 
solving. We asked participants to complete a Brain Performance Test (BPT) to measure 
their cognitive ability. In order to do the test, individuals had to sign into Lumosity using 
their electronic devices. Individuals were not asked to travel to our lab to do the test. 
The BPT includes 10 different tasks. Each task assesses a unique cognitive ability 
(Table 2). For each task, participants get a separate score or time or both. 
We matched each one of our subjects to 100 controls based on sex, age, and 
level of education. The results of BPT tests for matched controls were received from 
Lumosity. We assumed that controls did not have a 15q11.2 deletion, since the 
prevalence of this deletion in general population is known to be low. We calculated the 
mean of BPT scores of controls in each group. We compared each subject’s score or 
finish time to a mean score for a population of 100 matched controls. We tested for 
significant differences between deletion carriers and controls using one-tailed Wilcoxon 
Signed-Rank test. A threshold of p < 0.05 was employed to assess significance.  
 
 
Table 1: Sex, Age, and Education Level Breakdown of Participants 
Sex	   Female	   19	  
Male	   8	  
Age	   10-­‐20	   8	  
20-­‐30	   2	  
30-­‐40	   10	  
40-­‐50	   2	  
50-­‐60	   5	  
Education	  level	   Some	  school	   9	  
High	  school	   7	  
Associates	  degree	   3	  
Bachelors	  degree	   2	  
Master’s	  degree	   4	  

























Attend to two target letters. Four 
letters are briefly flashed inside four 
circles at a particular eccentricity, 
followed by a mask. Click on circles 
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Recall the spatial location and 
sequence of highlighted boxes by 
clicking in the forward order 
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Table 3: Results, Significant Findings in Bold 
Task Mean for 
deletion carrier 
participants 
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Graph 1: Grammatical Reasoning Score, deletion score minus controls score 
 
 
























































 We report here on the cognitive ability of a cohort of 27 individuals with 15q11.2 
deletion, who are not affected or are minimally affected. We compared the performance 
of our participants to controls matched to each participant based on age, education level 
and sex on 10 different tasks included in the BPT. We found statistically significant 
differences between our cohort and the control populations, using Wilcoxon Signed-
Rank test, in four cognitive tasks: Grammatical reasoning, Wordy equations, Digit 
symbol coding, and Reverse span board (Table 3). We performed a statistical analysis 
excluding outliers, and still found significant differences for the aforementioned tasks. 
 As described in table 2, in the Grammatical Reasoning task, designed to assess 










the net correct number (score) and the time to complete the task were recorded for 
each individual. In comparing individuals with a deletion against the mean scores of 
matched controls, individuals with a deletion consistently answered fewer questions 
correctly and had slower times.  Collectively, the differences in score and time were 
significant, with p values of 0.00187 and 0.00135 respectively. Each point in Graphs 1 
and 2 represents a deletion carrier score or time minus the mean score or time of the 
100 controls that matched the participant based on covariates. In Graph 1, 22 out of 27 
points lie under the zero, demonstrating that the majority of deletion carriers performed 
worse. In Graph 2, 21 out of 27 points lie above the zero line for time, demonstrating 
that the majority of deletion carriers took more time to finish the task.  
  
 In the Wordy Equation task, participants were asked to answer arithmetic 
questions to assess arithmetic problem solving ability (Table 2). Individuals with 15q11.2 
deletion had lower scores than individuals with the same age, sex, and education level 
in arithmetic problem solving tasks in most instances, and collectively the differences 
were significant, with a p value of 0.00144. Graph 3 presented individual level data for 
all deletion carriers.  Each point in Graph 3 represents a deletion carrier score minus the 
mean of 100 scores for matched controls, and 20 out of 27 points lie under the zero line. 
 
 In the Digit Symbol Coding task, designed to assess visual speed of processing, 
individuals were asked to determine how many items appeared on the screen. Although 
the p value of 0.00734 calculated for the Digit Symbol Coding task is significant, and 19 
out of 27 points in graph 5, which represent deletion carrier score minus the controls, lie 
under the zero line, the differences are less pronounced than those in tests of arithmetic 
problem solving and logical reasoning.  In addition, the time component of this test, 
while slower on average for most deletion carriers (Graph 5), was not statistically 
significant overall. Further studies are required to confirm the association between 
15q11.2 deletion and decreased ability of visual speed of processing. 
 In the Span Board and Reverse Span Board tasks, individuals were asked to 
recall the location and sequence of highlighted boxes and click in the forward or reverse 
order, respectively (Table 2). Deletion carriers correctly identified location and sequence 
less often than matched controls in both the Span Board and Reverse Span Board 
tests, but the p value for Reverse Span Board test was significant  (p=0.00347) while 
the p value for span board test was not (p=0.951). Since both tasks are very similar and 
both measure visual-spatial working memory, the lack of concordance suggests that 
current data is inadequate to determine the extent of cognitive differences between 
participants and the control population. Since the Reverse Span Board task is more 
difficult than the forward Span Board task, it may be that deletion carriers and controls 
perform equally well in visual-spatial working memory tasks when those tasks are 
routine, and less well in tasks that are more challenging. Further studies are needed to 
investigate this hypothesis.  
 Although on average deletion carriers scored lower and performed slower in all 
the tasks included in BPT (Table 3), in addition to the tasks mentioned above, the 
difference was not significant for Divided Visual Attention, Progressive Matrices, Go/No-
go Reaction, and Trail Making And B tasks. These tasks were designed to assess 
divided visual attention, flexibility, speed of processing and task switching. The absence 
of significant finding in these tasks could be due to the fairly small sample size of this 
study. Further investigations in the future with larger sample sizes may be beneficial. 
 As discussed, Stefansson et al, in 2014, showed that the performance of 15q11.2 
carriers on select tests fell between that of non-carriers and patients with schizophrenia. 
Stefansson used traditional approaches, such as the M.I.N.I test for assessing cognitive 
ability (Stefansson et al, 2014). Typically, only a limited and homogeneous sample 
could be studied with this approach, since the participants were required to physically 
travel to the research lab. Our study utilized an online research database, Lumosity, 
which permitted a more heterogeneous population. In fact, with regards to geographical 
location, the cohort for the present study has been recruited from across the United 
States and Canada.  
 Since the emergence of Lumosity in 2007, there have been several studies 
suggesting Lumosity’s effectiveness with regards to measuring cognitive ability 
(Sternberg, 2013; Tartaglione, 2014). Recently, Tartaglione et al, compared usage of 
Lumosity training games to currently widely used psychometric tests to investigate the 
cognitive differences. Tartaglione concluded that Lumosity games could be a useful tool 
to test for small cognitive impairments, which sometimes cannot be detected by more 
conventional testing (Tartaglione, 2014). Therefore, using Lumosity in this study, may 
have helped to detect previously unobserved small cognitive differences between 
15q11.2 deletion carriers and controls. 
  In the future, the use of online cognitive training games could be investigated as 
a potential vehicle to improve the Logical reasoning and arithmetic problem solving 
skills of individuals with 15q11.2 deletion. 
Conclusion 
 15q11.2 deletion has been reported to be associated with a number of 
neurobehavioral phenotypes. Some carriers of this deletion manifest clinical symptoms, 
while others do not. In this study, we showed that symptomless individuals with 15q11.2 
deletion perform worse than the general population in tasks that involve arithmetic 
problem solving and logical reasoning, providing evidence for the presence of an 
intermediate cognitive phenotype in all individuals with 15q11.2 deletion.  
 This study suggests more complete penetrance for lowered problem solving and 
logical reasoning ability associated with 15q11.2 deletion. Individuals however, show 
variable degrees of expression for these cognitive phenotypes, ranging from mildly 
affected individuals who appear to be symptomless to individuals who are severely 
affected and have diagnosis of cognitive disabilities. Therefore, even though some 
individuals with 15q11.2 function within the norm in the general population, their 
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